Femasys (FEMY) CEO Kathy Lee‑Sepsick Buys Stock, Receives Warrants

What Happened

• Kathy Lee‑Sepsick, CEO of Femasys Inc. (FEMY), made an open‑market/private purchase of 15,625 shares of common stock at $3.20 per share on August 7, 2026, paying $50,000 in aggregate. On the same date she was also issued two derivative awards (each reporting 15,625 share equivalents) — reported as grants/awards (derivatives), not immediate common‑stock issuances.

Key Details

• Transaction date: August 7, 2026; Form 4 filed August 11, 2026.
• Purchase: 15,625 common shares at $3.20/share = $50,000 (per filing / Securities Purchase Agreement).
• Awards/derivatives: two grants of 15,625 share equivalents each (reported as "A" — award/derivative).
• Warrant/exercise terms: the Common Warrant may be exercised at $2.95/share (subject to adjustment); exercise is subject to Nasdaq limitations. One of the warrants is a milestone‑based warrant that is exercisable only after specified revenue and price milestones are met (milestone date on or after Aug 10, 2027) and has an uncertain expiration date per the filing.
• Aggregate potential shares from these transactions: 15,625 purchased + 2 × 15,625 derivative interests = 46,875 total shares/rights (if all derivatives ultimately convert/exercised).
• Shares owned after the transaction: not disclosed in the Form 4 filing.
• No 10b5‑1 plan or tax‑withholding sale reported in the filing.

Context

• The cash purchase is a straightforward insider buy (direct purchase of common stock). The two derivative awards are warrants/rights with conditions: one is a typical exercisable warrant (exercise price noted at $2.95) and the other is tied to performance milestones and may not be exercisable until those milestones are met (and its expiry is indeterminate today). Derivative awards do not represent immediate common‑stock ownership until exercised/vested and may be subject to market‑based and regulatory limits.